biogen idec inc (IDP:Frankfurt)
As of 11:17 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - biogen idec inc (IDP)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Nancy Leaming | 38 Relationships | Director and Chairman of Finance & Audit Committee | Biogen Idec Confirms SEC Probe of Trading 04/29/05 |
| Stelios Papadopoulos Ph.D. | 104 Relationships | Director, Member of Finance & Audit Committee and Member of Science & Technology Committee | Biogen Idec Inc. announced delayed 10-Q filing 08/10/06 |
| Brian Posner | 46 Relationships | Director, Member of Corporate Governance Committee and Member of Finance & Audit Committee | Biogen Idec Inc. announced delayed annual 10-K filing 03/17/05 |
| Caroline Dorsa | 29 Relationships | Director and Member of Finance & Audit Committee | Biogen Idec Inc. Revised Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2004 04/4/05 |
Finance Committee* - biogen idec inc (IDP)
| Name(Connections) | Board Relationships | Title |
| Caroline Dorsa | 29 Relationships | Director and Member of Finance & Audit Committee |
| Nancy Leaming | 38 Relationships | Director and Chairman of Finance & Audit Committee |
| Stelios Papadopoulos Ph.D. | 104 Relationships | Director, Member of Finance & Audit Committee and Member of Science & Technology Committee |
| Brian Posner | 46 Relationships | Director, Member of Corporate Governance Committee and Member of Finance & Audit Committee |
| Debt To Total Capitalization | 11.1x |
It is important for the finance committee to know when to issue debt or equity.
Management/Organization Development Committee* - biogen idec inc (IDP)
| Name(Connections) | Board Relationships | Title |
| Alexander Denner Ph.D. | 36 Relationships | Director, Member of Compensation & Management Development Committee and Member of Corporate Governance Committee |
| Robert Pangia | 61 Relationships | Director and Chairman of Compensation & Management Development Committee |
| Eric Rowinsky M.D. | 68 Relationships | Director, Member of Science & Technology Committee and Member of Compensation & Management Development Committee |
| Lynn Schenk J.D. | 31 Relationships | Director, Chairman of Corporate Governance Committee and Member of Compensation & Management Development Committee |
| Rank Against Competitors | |
| Revenue/Employee | |
| $927.1K | 14 |
| Earnings/Employee | |
| $309.0K | 95 |
K = Thousand
M = Million
B = Billion
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| IDP:GR | €179.05 EUR | -1.25 |  |
| Company | Last | Change |
| Astellas Pharma Inc | ¥5,410 JPY | -70.00 |
| Becton Dickinson and Co | $100.83 USD | +0.66 |
| Celgene Corp | $122.58 USD | -1.06 |
| Regeneron Pharmaceuticals Inc | $250.31 USD | -4.56 |
| Shire PLC | 2,168 GBp | +34.00 |
| View Industry Companies | ||
Industry Analysis
IDP
Industry Average
| Valuation | IDP | Industry Range |
| Price/Earnings | 37.4x |
|
| Price/Sales | 9.9x |
|
| Price/Book | 7.6x |
|
| Price/Cash Flow | 32.6x |
|
| TEV/Sales | 9.6x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
